FasoracetamvsHoly Basil (Tulsi)

Fasoracetam upregulates GABA-B receptor (GABA-B1/GABA-B2 heterodimer) expression and function, which is unique among racetams — this receptor upregulation is potentially beneficial for restoring GABAergic sensitivity after prolonged benzodiazepine or phenibut use. It enhances group II metabotropic glutamate receptor (mGluR2/mGluR3) signaling, which modulates presynaptic glutamate release and reduces excitotoxicity. Fasoracetam increases acetylcholine release in the cerebral cortex via modulation of choline acetyltransferase activity and vesicular acetylcholine transporter function. It may also modulate the glutamatergic system through mGluR5. The combination of GABAergic (GABA-B-mediated inhibition), glutamatergic (mGluR modulation), and cholinergic enhancement provides anxiolytic effects alongside cognitive enhancement. Clinical trials focus on ADHD patients with GRM (glutamate receptor) gene variants.

Holy basil's adaptogenic effects come from multiple compounds: eugenol (anti-inflammatory via COX-2 and 5-LOX inhibition, TRPV1 modulation), ursolic acid (cortisol modulation via 11beta-HSD inhibition and glucocorticoid receptor modulation), rosmarinic acid (antioxidant via Nrf2/ARE pathway, anti-allergic via mast cell stabilization), and ocimumosides A and B (anti-stress via CRH and corticosterone reduction). It modulates the HPA axis, normalizing cortisol and corticosterone levels through hypothalamic and adrenal effects. Ursolic acid inhibits acetylcholinesterase (AChE), mildly increasing synaptic acetylcholine. Eugenol provides direct anxiolytic effects through GABA-A receptor positive allosteric modulation (possibly at the beta2/3 subunit interface) and 5-HT1A partial agonism. Ocimumosides may reduce ACTH release from the pituitary.